Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.
Seifi S, Pouya F, Rahmani M, Mehramiz M, Rastgar-Moghadam A, Gharib M, Rahmani F, Shahidsales S, Hassanian SM, Khazaei M, Dadjoo P, Parvin SS, Yazdinezhad Y, Parizadeh SMR, Ferns GA, Fathi M, Avan A.
Seifi S, et al. Among authors: mehramiz m.
J Cell Physiol. 2020 Jun;235(6):5141-5145. doi: 10.1002/jcp.29388. Epub 2019 Nov 12.
J Cell Physiol. 2020.
PMID: 31721206